Every six months Jack has a TrialNet appointment at Joslin with an OGTT. Today was the day for one of those. A few things were different this time. Different thing one: DT #1 was my perspective. I’d read more about teplizumab, the experimental drug (or its placebo) that was infused into Jack for two weeks, two years ago. I’d … Continue reading ![]()
